Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brett A. Grimaud Insider Profile
4 Followers
Brett A. Grimaud, SVP, GEN COUNSEL AND SECRETARY at Theravance Biopharma, holds 333.35K shares in Theravance Biopharma (Ticker: TBPH).
Brett A. Grimaud has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Brett A. Grimaud's holdings
Insider Roles
SVP, GEN COUNSEL AND SECRETARY
Roles that Brett A. Grimaud holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brett A. Grimaud
Brett A. Grimaud's Trading History
List of latest transactions for each holding click on a transaction to see Brett A. Grimaud's performance on stock
You May Also Like
Brett A. Grimaud insider profile FAQ
What is the percentage of profitable transactions made by Brett A. Grimaud?
The percentage of profitable transactions made by Brett A. Grimaud is ―.
What is the average return per transaction made by Brett A. Grimaud?
The average return per transaction made by Brett A. Grimaud is ―.
What stocks does Brett A. Grimaud hold?
Brett A. Grimaud holds: TBPH stocks.
What was Brett A. Grimaud’s latest transaction?
Brett A. Grimaud latest transaction was an Uninformative Sell of $92.40K.
What was Brett A. Grimaud's most profitable transaction?
Brett A. Grimaud’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brett A. Grimaud's role in Theravance Biopharma?
Brett A. Grimaud's role in Theravance Biopharma is SVP, GEN COUNSEL AND SECRETARY.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.